Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice – Which to Use Regarding Disease Outcomes (2021) Alain Menzel

Description

This review analyzes common and novel biomarkers used to measure inflammation and oxidative stress (OS) ex vivo in research and clinical practice. It addresses the need for valid, stable, and affordable markers to monitor chronic conditions (like cancer, diabetes, and cardiovascular diseases) and evaluate treatment efficacy, detailing standard acute-phase proteins (e.g., CRP, cytokines) and newer markers (e.g., lipid peroxidation products).